Is SARS-CoV-2 transmitted by asymptomatic and pre-symptomatic individuals?
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Asymptomatic_transmission_Abridged_26June2020_version4_AFM,KLRFor any questions or information, please email: covidrapidreviewteam@gmail.com.
Asymptomatic_transmission_Abridged_26June2020_version4_AFM,KLRFor any questions or information, please email: covidrapidreviewteam@gmail.com.
Hemoperfusion Abridged 17Apr2020For any questions or information, please email: covidrapidreviewteam@gmail.com.
Sedation abridged 15Apr2020 V1 CTLFor any questions or information, please email: covidrapidreviewteam@gmail.com.
RAS antagonists abridged 1MAY2020 V 2.0For any questions or information, please email: covidrapidreviewteam@gmail.com.
Leronlimab 29 abridged Apr 2020 Version 2 LR EBFor any questions or information, please email: covidrapidreviewteam@gmail.com.
Anticoagulation Abridged 24APR2020 Version2 EOS JMA PPR
For any questions or information, please email covidrapidreviewteam@gmail.com.
IVIg Abridged V2 10July2020 Revised (1) – CopyFor any questions or information, please email covidrapidreviewteam@gmail.com.
Nitric Oxide_Abridged_11Apr_ver1_KLR,AFM
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Convalescent Plasma Abridged V4 13April 2020
For any questions or information, please email covidrapidreviewteam@gmail.com.
Xray_Abridged V3 10Apr2020 TSJ IGC
Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.